A new study has suggested that protein supplements could help control type 2 diabetes.
The research, which was conducted by a team at the University of Surrey, found that when people with type 2 diabetes were given a protein supplement, it helped to control their blood sugar levels.
Speaking about the findings, lead researcher Dr. Emma Allerton said that the findings could “help to improve the management of type 2 diabetes.”
“Our findings show that just a small amount of protein before meals can have a significant impact on blood sugar levels,” she explained.
“This is because protein takes longer to be broken down and used by the body than carbohydrates, which means that it helps to regulate the release of sugar into the blood.”
Dr. Allerton said that the findings could have implications for the way in which type 2 diabetes is treated in the future.
“This research provides new insight into the role of protein in blood sugar control and could lead to the development of new dietary interventions for type 2 diabetes,” she said.
The study is published in the journal Diabetes, Obesity and Metabolism.
A new study has suggested that protein supplements may help to control type 2 diabetes. The research, which is still in its early stages, was conducted on rats, and shows that a protein called FGF21 may help to improve insulin sensitivity and reduce blood sugar levels.
FGF21 is a hormone that is produced by the liver in response to fasting, and is known to play a role in glucose metabolism. This latest study, conducted by scientists at Baylor College of Medicine, shows that when rats were given FGF21 supplements, their insulin sensitivity improved, and their blood sugar levels were significantly lower than those of rats who were not given the supplement.
While the research is still in its early stages, and has yet to be replicated in humans, it provides a potential new avenue for the treatment of type 2 diabetes. If further studies confirm the findings, it may be possible to use FGF21 supplements to help control blood sugar levels in people with diabetes.
There are currently no medications available that specifically target FGF21, but the researchers hope that this will change in the future. In the meantime, the findings of this study offer a new perspective on the role of protein in the management of diabetes, and may help to improve the lives of those affected by this condition.
